Research Triangle Park, North Carolina, October 21, 2014 — Marken confirmed today that their global cold chain network will be expanded to respond to the growing need for just in time conditioning and preparation of temperature controlled packaging solutions.
By the end of 2014, Marken will have additional qualified equipment and capacity at all of its 30 locations. Marken’s dedicated focus on clinical trials and new GDP enforcement guidelines has generated a significant global increase in client requests for secure, just in time temperature control of Investigational Medical Product (IMP) shipments.
“Cost pressures and the challenge of managing global durable packaging solutions are driving Pharma companies to look for solid partnerships who offer a strong, reliable network for clinical trial supplies”, said Dan Bell, Marken’s Vice President Regulatory Compliance and Technical Affairs. “The increased regulatory scrutiny and requirement for a GDP compliant supply chain is driving us to increase our capacity and manage a growing number of phase change temperature controlled solutions.”
Marken will announce new developments in their logistics network in the coming weeks.
Marken is the leading global clinical supply chain solutions provider dedicated to the pharmaceutical and life sciences industries, supporting over 49,000 clinical investigators in more than 150 countries. Marken integrates depot and logistics into solutions that extend the reach of clinical trials to even the most remote treatment-naive geographies.
CONTACT: Christine Noble, email@example.com, +1 919 474 6890, www.marken.com